Trichomoniasis vaginalis is the most common nonviral sexually transmitted infection (STI), with an estimated 170 million cases occurring annually. Information regarding the prevalence of trichomoniasis vaginalis is scarce because this infection receives only limited public health attention. Perhaps the most generalizable data comes from the Four Cities study [1] . As a part of this large-scale project aimed at understanding the variation in HIV prevalence in different parts of Africa, a representative sample was enrolled and tested for numerous risk factors, including Trichomonas vaginalis. Using culture to detect trichomonads, the authors of that study described prevalences ranging from 3.2% to 34.3%, with significantly higher prevalences in the 2 cities with a high prevalence of HIV infection.
The relationship between T. vaginalis infection and HIV infection is similar to that between HIV infection and other STIs in that it may be bidirectional: T. vaginalis infection may increase transmission of HIV, and HIV infection may increase susceptibility to T. vaginalis in-fection. Biological interactions between T. vaginalis and HIV that may affect susceptibility to HIV infection have been described elsewhere [2] [3] [4] [5] . After receipt of metronidazole treatment by men infected with T. vaginalis, there was a marginally significant reduction in HIV load in the seminal compartment (P ϭ .052) [6] . Although the study was limited by small enrollment, the results suggest that control of T. vaginalis in men may reduce the probability of transmitting HIV. Similar results were obtained for women in an assessment of vaginal swab specimens for HIV load before and after treatment for trichomoniasis vaginalis [5] . Of interest, although treatment of both Candida vulvovaginitis and trichomoniasis vaginalis resulted in a significant reduction in HIV load (P Ͻ .001), treatment for bacterial vaginosis did not have a measurable effect.
Several epidemiologic studies have attempted to define the effect of nonulcerative STI, including T. vaginalis infection, on the susceptibility to HIV infection. The most convincing data demonstrating a relationship between infection with T. vaginalis and HIV acquisition comes from studies performed in cohorts of female sex workers (FSWs). The investigation of STI and HIV infection in a cohort in Zaire by Laga et al. [7, 8] used culture of specimens obtained at monthly visits to detect trichomonads. The adjusted odds ratio (OR) for HIV acquisition was 1.9 (95% confidence interval [CI], 0.9 -4.1)-a marginally significant result. However, in a survival analysis of the same data, the authors described an adjusted relative risk of 1.7 (95% CI, 1.1-2.8). An excellent review by Røttingen et al. [9] summarized the findings of 8 longitudinal studies that specifically measured the relationship between T. vaginalis infection and HIV acquisition. Although only 1 study found a significant association between T. vaginalis infection and HIV acquisition, the overall effect estimate was 1.5 (95% CI, 1.2-2.0). Similar findings were observed in a meta-analysis performed by Sexton et al. [10] The authors estimated the effect of T. vaginalis infection on the risk of HIV acquisition to be 1.59 -2.10, using various analysis scenarios. More-recent data from another FSW cohort in Kenya has since confirmed the findings of Laga and colleagues, using a similar study design (HR, 1.52; 95% CI, 1.04 -2.24) [11] .
Given the biological plausibility and the mathematical modeling that suggests that T. vaginalis infection should increase risk of HIV acquisition, it is surprising that there are so little data to support this hypothesis. This may, in part, be attributable to the limitations associated with all studies attempting to define the relationship between the presence of an STI and the susceptibility to HIV infection. Study design issues are well described elsewhere [12, 13] but include case ascertainment bias; lengthy time between follow-up; confounding by sexual behaviors, particularly those of the partner and the sexual network; and lack of external validity, which is attributable to the need to perform studies in high-risk populations, such as FSWs. We designed a nested case-control study, using samples collected from women as part of a larger study of the effect of hormonal contraception on HIV acquisition, in an effort to more precisely measure the association between trichomoniasis vaginalis and HIV acquisition in a general population cohort of women from Uganda and Zimbabwe.
SUBJECTS, MATERIALS, AND METHODS
Study population and sample collection. Data and samples were from a longitudinal study of hormonal contraception and HIV acquisition in Uganda and Zimbabwe, which has been described in detail elsewhere [14] . In brief, participants were aged 18 -35 years and negative for HIV at enrollment. In Uganda, 1837 women were recruited from family planning clinics, and 398 women were enrolled from high-risk referral settings, such as STI clinics or FSW networks. In Zimbabwe, 2296 women were enrolled at family planning clinics. Participants were seen in clinic every 3 months for up to 24 months. Informed consent was obtained from all study participants, and approval for all protocols was obtained from institutional review boards at participating institutions.
Samples collected for diagnostic detection of STI and reproductive tract infections at each visit included vaginal swabs for wet mount microscopy and cervical swabs for Chlamydia trachomatis and Neisseria gonorrhoeae polymerase chain reaction (CT/NG PCR) analysis. Participants with any positive test results were subsequently treated for the infection. Blood was collected for herpes simplex virus type 2 (HSV-2), Treponema pallidum, and HIV-1 by serological analyses, and dried blood spots were stored for retrospective HIV DNA PCR testing. Incident HIV infection was identified in 218 women; 63 were in Uganda, and 155 were in Zimbabwe. These women were classified as cases for the nested case-control study described here. Control subjects were matched on the basis of study site, age, a composite STI variable, and length of study follow-up. The composite STI variable, consisting of C. trachomatis infection, N. gonorrhoeae infection, or bacterial vaginosis but not yeast infection, was chosen to control for exposures and route of transmission rather than to detect interactions among specific pathogens. The composite STI variable was set to 1 if a participant was infected with C. trachomatis or N. gonorrhoeae or had bacterial vaginosis at either the visit HIV infection was detected or the previous visit. The composite STI variable was set to 0 for women who tested negative for all 3 of these conditions at both visits. Matching was performed on the basis of this variable, both to control for the presence of other sexually transmitted pathogens and to maximize the number of case-control sets that could be included in an analysis of women with no other treatable STI during the period of interest. Four controls were identified per case and prioritized on the basis of the matching testing criteria; the closest match was priority 1, and the weakest match was priority 4. This allowed us to locate 2 controls per case, assuming that some samples would be missing from the study repository. For cases, analyzed samples were from the visit in which HIV seroconversion was detected and the visit preceding detection of seroconversion; for controls, one analyzed sample was from the visit matched by follow-up duration to the cases' seroconversion visit, and the other sample was from the visit immediately preceding the matched visit.
Behavioral and risk measures. On the basis of findings of the parent study analyses [14] , composite variables were created for measures that were highly correlated and resulted in collinearity during multivariable modeling. Participant behavioral risk was measured using 3 variables based on behavior during the previous 3 months: having multiple sex partners, having a new sex partner(s), and any commercial sex work. For this analysis, these variables were combined into a composite dichotomous variable. A response of "yes" to any of the sexual risk variables was categorized as "yes" for participant behavioral risk. Primary sex partner-associated risk was also measured using a composite variable based on responses to multiple questions in the interview. These included having a partner with HIV infection, urethral discharge, weight loss, nights spent away from home, or a history of sex with FSW. Measures of sexual behaviors during the previous 3 months included coital frequency and percentage of coital events that were unprotected. On the basis of the distribution observed, this variable was condensed to the following levels: 0, Ͼ0 -50, and Ͼ50 -100 unprotected coital events.
STI symptoms were restricted to the participant's selfreported symptoms for this analysis. These included abnormal vaginal discharge, vaginal itching, pelvic pain, pain during sex, and irregular bleeding. Responses were combined into a composite variable, as described above. The exposure of interest for this study was the presence of T. vaginalis before infection with HIV. T. vaginalis infection status was determined on the basis of wet mount microscopy data from the parent study, as well as findings of T. vaginalis DNA PCR analysis of case and control samples.
Diagnosis of vaginal infections and STIs. Vaginal swabs were collected in saline for a KOH whiff test and wet mount microscopy to identify yeast buds or pseudohyphae, motile trichomonads, or clue cells. Bacterial vaginosis was diagnosed on the basis of Amsel criteria. Cervical swabs were placed in Amplicor CT/NG transport medium (Roche Diagnostics) for CT/NG PCR. The US package insert was used for interpretation of results, with 1 exception: the cutoff for N. gonorrhoeae positivity was an optical density at 450 nm absorbance of 2.500, because of a limitation with local plate readers. This deviation from US criteria remains more stringent than criteria used in European package inserts and should not have substantively reduced specificity [15] . T. vaginalis PCR was performed using the residual processed cervical sample, which had been stored at Ϫ20°C to Ϫ80°C since original CT/NG testing. This assay has been described elsewhere [16] . In brief, samples processed for CT/NG PCR were added to the Amplicor master mix containing T. vaginalis-specific primers for amplification. Following amplification, T. vaginalis DNA sequence was detected using a speciesspecific probe in an enzyme linked immunoassay (EIA) format.
HSV-2 serological analysis was performed using a commercially available EIA assay (Focus Diagnostics). HIV diagnosis was based on serological findings, using EIA with confirmation by positive results of a Western blot and at least 1 rapid test. Timing of HIV infection was based on findings of HIV DNA PCR analysis (Amplicor, version 1.5) of dried blood spot samples obtained during visits when serological tests were negative for HIV. After serological confirmation of infection, specimens from previous visits were tested serially by HIV DNA PCR until a negative result was obtained. The HIV infection visit was defined as the earliest HIV DNA PCR-positive visit, which may have occurred 3-6 months before the first HIV seroconversion visit. The latest HIV DNA PCR-negative visit was labeled the last HIV-negative visit.
Analyses. All selected cases with matched controls were included in this analysis. Although the study aimed to have 2 controls per case (i.e., 1:2 matching), some cases had only 1 control because of missing visits and/or loss of samples. The weighted Mantel-Haenszel OR was used to estimate the association between T. vaginalis infection and HIV acquisition. Conditional logistic regression, performed using SAS statistical software (SAS Institute), was used for our primary analyses, which did not include the matching variables. Forward variable selection procedures were used to finalize the regression model. To evaluate the effect of matching, the final model was evaluated using unconditional logistic regression and included the matching variables to assess the effect of the matching strategy on our study results [17] .
RESULTS
Population characteristics. Samples were available from 213 (97.7%) of 218 women who seroconverted during the parent study. Twenty-four (11.2%) of these women had positive HIV DNA PCR results at the visit 3 months before results of serological tests were positive. Cases were matched to 419 women who remained HIV negative through the study follow-up period. The median ages at enrollment were 24 years for the cases and the controls. The median number of days between the visit during which HIV infection was detected and the last visit during which HIV was not detected was 84.0 days. For controls, a median of 83.0 days passed between the visits from which samples obtained for testing. At enrollment, women who would subsequently seroconvert were also significantly more likely to not be living with a partner, to have a higher participant behavioral risk, and to report more-consistent condom use. There were no baseline differences between cases and controls with respect to age, educa-tion level, number of pregnancies, STI symptoms or history, or coital frequency.
T. vaginalis. T. vaginalis PCR detected 37 infections at the visit during which HIV was detected and 43 infections during the previous visit. By comparison, microscopy detected only 17 and 24 infections, respectively (P Ͻ .001 for both comparisons), at these visits. Although microscopy is a useful diagnostic tool in resource-constrained settings, DNA-based diagnostic tests are becoming increasingly available in other settings. To understand the importance of infections that are detectable only by DNAbased testing, we looked at subjects with wet mount microscopy-negative, PCR-positive results. When analysis was restricted to infections identified only by PCR, 5.7% of cases and 2.9% of controls were infected with T. vaginalis; this was not a statistically significant difference (P ϭ .096). All but 1 (93.3%) of the infections identified by microscopy at the visit immediately before HIV infection was detected were treated with metronidazole, whereas 17 infections (8 in controls [42.1%] and 9 in cases [37.5%]) identified only by means of T. vaginalis PCR were not treated. There was no statistical difference in treatment rates between cases and controls. The presence of symptoms in women with T. vaginalis infection was also equally distributed among cases and controls (26.3% and 20.0%, respectively).
Univariate analyses. T. vaginalis infection was strongly associated with HIV infection, regardless of the diagnostic method (table 1). All further analyses were performed using T. vaginalis PCR findings from the last HIV-negative visit as the exposure of interest, because of the clear temporal relationship between these findings and HIV acquisition. We also examined differences based on the method of diagnosis at the previous visit. In this analysis, the distribution of PCR-positive, wet mount microscopy-negative results, which occurred for 22 women, was not statistically different from either PCR-negative results or wet mount microscopy-positive results for cases and controls (P ϭ .096 and P ϭ .491, respectively, by the 2 test). The prevalence of PCR-positive, wet mount microscopy-negative results at the visit before HIV infection was detected was 2.9% among cases and 5.7% among controls (P ϭ .096), suggesting that this may be an important difference, but the reduction in sample size necessary for this analysis may have reduced the power to confirm the statistical significance of this difference.
The point prevalences of STI and symptoms at the visit before detection of HIV infection were compared among cases and controls (table 1) . HSV-2 seropositivity was strongly associated with an increased risk of HIV acquisition (P Ͻ .001), whereas detection of yeast was only marginally associated (P ϭ .074). The presence of STI symptoms was not included in the multivariable modeling because it was considered to be a probable outcome of trichomoniasis vaginalis and would have resulted in overcontrolling. Demographic and behavioral variables that were significantly associated with an increased risk of HIV infection included not living with partner, participant behavioral risk, recruitment setting (high-risk referral clinic vs. family planning clinic), and primary sex partner-associated risk (table 2) .
Multivariable analyses. Women who received a diagnosis of T. vaginalis infection at the previous visit were more likely than women without T. vaginalis infection at this visit to test positive for HIV infection at the following visit (adjusted OR, 2.74; 95% CI, 1.25-6.00) (table 3). Other significant factors included a protective effect of living with a partner and an increased risk associated with participant behavioral risk, recruitment setting (i.e., high-risk referral clinic), primary sex partnerassociated risk, and HSV-2 seropositivity. Although T. vaginalis infection was a significant risk factor for HIV infection when controlling for recruitment setting, we also fit the final model with only the (majority) subset of women recruited from family planning clinics. In this analysis, T. vaginalis remained a significant predictor of HIV infection (adjusted OR, 3.3; 95% CI, 1.36 -7.85; P Ͻ .01). In fact, the adjusted OR was even higher in this subgroup, suggesting that for women with less risk from sexual networks, infection with T. vaginalis infection is a very important risk factor for HIV infection.
Use of the same multivariable model, with wet mount microscopy findings rather than PCR findings as the exposure definition, revealed that the adjusted OR for HIV infection in T. vaginalis-infected women was 5.10 (95% CI, 1.80 -14.45). When matched variables were adjusted for in the multivariable model, the effect of T. vaginalis infection remained significant, with little effect on the adjusted OR (adjusted OR, 2.46; 95% CI, 1.22-4.96).
DISCUSSION
In this nested case-control study, we have demonstrated a strong association between infection with T. vaginalis, regardless of diagnostic method, and subsequent acquisition of HIV, while controlling for other STIs, vaginal infections, and behavioral risk factors. The effect estimate described here when using a PCR diagnostic assay (adjusted OR, 2.74) is higher than that previously described by Laga et al. [7, 8] and McClelland et al. [11] and somewhat higher than the estimates predicted by metaanalyses [9, 10, 12] . Our study included several unique factors designed to improve the precision of the estimate of the impact of T. vaginalis infection on HIV acquisition. First, to our knowledge, this is the first longitudinal study to measure this association in a general population group of women (i.e., patients at family planning clinics). As a result, the findings of this study are more likely generalizable to the vast majority of women of reproductive age worldwide, compared with studies conducted among FSW cohorts. Second, the use of highly sensitive nucleic acid amplification techniques for the diagnosis of C. trachomatis, N. gonorrhoeae, and T. vaginalis infections may have resulted in reduced bias attributable to misclassification of the exposure variable and of STIs that are potential confounders. Third, by using a combination of serological testing and HIV DNA-based PCR analysis, rather than seroconversion, for detection of HIV, we have been able to more precisely identify the visit preceding HIV infection and establish a temporal relationship. For 11.2% of the 213 women identified with incident infection, HIV PCR analysis of samples obtained from the visit 3 months before seroconversion yielded positive results. Use of DNA PCR to define incident infection allowed us to evaluate the T. vaginalis infection status of these women at the visit before the HIV DNA positive result. Finally, although matching may introduce selection bias, it may be useful in certain situations. The bias that may be introduced by matching is predominately toward the null hypothesis, as it equalizes groups before analysis [17] . However, in this study, the findings were highly robust even when matching variables were adjusted for in multivariable models. Although we acknowledge that matching is not an ideal component of study design, in this study it allowed us to determine the effect of T. vaginalis independently of the effect of other STIs. The robustness of these findings with and without inclusion of matching variables suggests that the results are likely to be generalizable to other populations. The study from which the samples and behavioral data were taken was designed to provide follow-up visits that were sufficiently frequent such that the lag time between testing should not have influenced the findings. In a study of the natural history of T. vaginalis infection in young women, the organism was detectable by T. vaginalis PCR for up to 3 months-the duration of the study's follow-up period-in the absence of treatment [18] . However, the impact of T. vaginalis infection on HIV susceptibility may vary by the stage of the HIV epidemic in any given setting [1] . Indeed, the Mwanza and Rakai studies have clearly indicated the importance of study design and setting to the interpretation and generalizability of the results [8, 11] .
Although T. vaginalis PCR was used for the classification of exposure in this study, the results based on wet mount microscopy findings were encouraging. T. vaginalis detection by wet mount microscopy was strongly associated with subsequent HIV infection (P ϭ .002). The OR for HIV acquisition was higher for the subset women with positive wet mount microscopy results than for all women with positive PCR results (ORs, 5.10 and 2.74, respectively). This finding may be a reflection of the organism load necessary for trichomonads to be observed microscopically. In instances where wet mount microscopy results were positive, the high organism load may be responsible for more disruption of the vaginal micro-environment, compared with instances where wet mount microscopy results are negative and PCR results are positive. Performing wet mount microscopy during clinic visits where clients can be treated for trichomoniasis vaginalis or bacterial vaginosis may be a valuable tool for reducing the risk of HIV infection, because wet mount microscopy is inexpensive and easy to perform. Furthermore, aggressive treatment of symptoms in settings where microscopy is not available may also be warranted, although no effect of treatment was seen in this analysis.
One of the inherent difficulties with estimating the impact of any STI on HIV acquisition is the shared mechanism for transmission. Exposure to any etiologic agent of STIs may occur simultaneously with exposure to HIV. It is difficult to accurately estimate an effect without knowing which women have been exposed to HIV. Unfortunately, partner testing was not available as part of the parent study. This factor was controlled for statistically by including the participants' perceptions of sex partnerassociated risk, but these perceptions are imprecise at best.
Although HSV-2 seropositivity remains the most significant sexually transmitted risk factor for HIV acquisition, control of viral infections is problematic, compared with control of T. vaginalis infection. On the basis of the findings of this study, public health organizations should be aware of the potential risk associated with trichomoniasis vaginalis, and efforts to better control this disease should be made. These findings are not only of importance to HIV control programs in sub-Saharan Africa. In the United States, the Centers for Disease Control and Prevention recommends improved STI control as a primary prevention strategy for controlling the spread of HIV [5, 19] . Populations at particular risk for HIV acquisition in the United States are also at increased risk for T. vaginalis infection [20] . In areas throughout the world where the prevalences of T. vaginalis and HIV infection are high, resources aimed at detecting and treating T. vaginalis infection may result in significant reductions in the spread of HIV infection.
